Related references
Note: Only part of the references are listed.Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Synthesis of EF24-tripeptide chloromethyl ketone: A novel curcumin-related anticancer drug delivery system
Aiming Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Tissue factor and tumor:: Clinical and laboratory aspects
Y Förster et al.
CLINICA CHIMICA ACTA (2006)
Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue factor (TF) in SGC-7901 gastric cancer cells
J Zhang et al.
CANCER BIOLOGY & THERAPY (2005)
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
BK Adams et al.
ANTI-CANCER DRUGS (2005)
Covalent polymer-drug conjugates
C Elvira et al.
MOLECULES (2005)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents
BK Adams et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans
B Jilma et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa - An ex vivo human study
EI Lev et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor
CB Hansen et al.
BLOOD (2001)
Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1
S Awasthi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)